: HOMO and LUMO orbital energies (in eV), ionization potentials I and electron affinities A (in eV), and global electronegativity χ, total hardness η, global electrophilicity ω, electrodonating power (ω − ), electroaccepting power (ω + ), and net electrophilicity ∆ω ± of ALT-711, ALT-946, Aminoguanidine, Carnosine, GLY-230, LR-9, Metformin, OPB-9195, Pentoxifylline, Pioglitazone, Pyridoxamine and Tenilsetam calculated with the M11 density functional and the Def2TZVP basis set using water as solvent simulated with the SMD parametrization of the IEF-PCM model. The upper part of the table shows the results derived assuming the validity of the KID procedure and the lower part shows the results derived from the calculated ∆SCF energies. Table S1B : Table S1A J Table S2A : HOMO and LUMO orbital energies (in eV), ionization potentials I and electron affinities A (in eV), and global electronegativity χ, total hardness η, global electrophilicity ω, electrodonating power (ω − ), electroaccepting power (ω + ), and net electrophilicity ∆ω ± of ALT-711, ALT-946, Aminoguanidine, Carnosine, GLY-230, LR-9, Metformin, OPB-9195, Pentoxifylline, Pioglitazone, Pyridoxamine and Tenilsetam calculated with the M11L density functional and the Def2TZVP basis set using water as solvent simulated with the SMD parametrization of the IEF-PCM model. The upper part of the table shows the results derived assuming the validity of the KID procedure and the lower part shows the results derived from the calculated ∆SCF energies. Table S2B : Table S2A J Table S3A : HOMO and LUMO orbital energies (in eV), ionization potentials I and electron affinities A (in eV), and global electronegativity χ, total hardness η, global electrophilicity ω, electrodonating power (ω − ), electroaccepting power (ω + ), and net electrophilicity ∆ω ± of ALT-711, ALT-946, Aminoguanidine, Carnosine, GLY-230, LR-9, Metformin, OPB-9195, Pentoxifylline, Pioglitazone, Pyridoxamine and Tenilsetam calculated with the MN12L density functional and the Def2TZVP basis set using water as solvent simulated with the SMD parametrization of the IEF-PCM model. The upper part of the table shows the results derived assuming the validity of the KID procedure and the lower part shows the results derived from the calculated ∆SCF energies. Table S3B : Table S3A J Table S4A : HOMO and LUMO orbital energies (in eV), ionization potentials I and electron affinities A (in eV), and global electronegativity χ, total hardness η, global electrophilicity ω, electrodonating power (ω − ), electroaccepting power (ω + ), and net electrophilicity ∆ω ± of ALT-711, ALT-946, Aminoguanidine, Carnosine, GLY-230, LR-9, Metformin, OPB-9195, Pentoxifylline, Pioglitazone, Pyridoxamine and Tenilsetam calculated with the MN12SX density functional and the Def2TZVP basis set using water as solvent simulated with the SMD parametrization of the IEF-PCM model. The upper part of the table shows the results derived assuming the validity of the KID procedure and the lower part shows the results derived from the calculated ∆SCF energies. Table S4B : Descriptors J I , J A , J HL , J χ , J η , J ω , J D1 , J ω + , J ω − , J ∆ω ± and J D2 for the ALT-711, ALT-946, Aminoguanidine, Carnosine, GLY-230, LR-9, Metformin, OPB-9195, Pentoxifylline, Pioglitazone, Pyridoxamine and Tenilsetam molecules calculated from the results of Table S4A J Table S5A : HOMO and LUMO orbital energies (in eV), ionization potentials I and electron affinities A (in eV), and global electronegativity χ, total hardness η, global electrophilicity ω, electrodonating power (ω − ), electroaccepting power (ω + ), and net electrophilicity ∆ω ± of ALT-711, ALT-946, Aminoguanidine, Carnosine, GLY-230, LR-9, Metformin, OPB-9195, Pentoxifylline, Pioglitazone, Pyridoxamine and Tenilsetam calculated with the N12 density functional and the Def2TZVP basis set using water as solvent simulated with the SMD parametrization of the IEF-PCM model. The upper part of the table shows the results derived assuming the validity of the KID procedure and the lower part shows the results derived from the calculated ∆SCF energies. Table S5A J Table S6A : HOMO and LUMO orbital energies (in eV), ionization potentials I and electron affinities A (in eV), and global electronegativity χ, total hardness η, global electrophilicity ω, electrodonating power (ω − ), electroaccepting power (ω + ), and net electrophilicity ∆ω ± of ALT-711, ALT-946, Aminoguanidine, Carnosine, GLY-230, LR-9, Metformin, OPB-9195, Pentoxifylline, Pioglitazone, Pyridoxamine and Tenilsetam calculated with the N12SX density functional and the Def2TZVP basis set using water as solvent simulated with the SMD parametrization of the IEF-PCM model. The upper part of the table shows the results derived assuming the validity of the KID procedure and the lower part shows the results derived from the calculated ∆SCF energies. Table S6B : Table S6A J Table S7A : HOMO and LUMO orbital energies (in eV), ionization potentials I and electron affinities A (in eV), and global electronegativity χ, total hardness η, global electrophilicity ω, electrodonating power (ω − ), electroaccepting power (ω + ), and net electrophilicity ∆ω ± of ALT-711, ALT-946, Aminoguanidine, Carnosine, GLY-230, LR-9, Metformin, OPB-9195, Pentoxifylline, Pioglitazone, Pyridoxamine and Tenilsetam calculated with the SOGGA11 density functional and the Def2TZVP basis set using water as solvent simulated with the SMD parametrization of the IEF-PCM model. The upper part of the table shows the results derived assuming the validity of the KID procedure and the lower part shows the results derived from the calculated ∆SCF energies. Table S8A : HOMO and LUMO orbital energies (in eV), ionization potentials I and electron affinities A (in eV), and global electronegativity χ, total hardness η, global electrophilicity ω, electrodonating power (ω − ), electroaccepting power (ω + ), and net electrophilicity ∆ω ± of ALT-711, ALT-946, Aminoguanidine, Carnosine, GLY-230, LR-9, Metformin, OPB-9195, Pentoxifylline, Pioglitazone, Pyridoxamine and Tenilsetam calculated with the SOGGA11X density functional and the Def2TZVP basis set using water as solvent simulated with the SMD parametrization of the IEF-PCM model. The upper part of the table shows the results derived assuming the validity of the KID procedure and the lower part shows the results derived from the calculated ∆SCF energies. 
